World ADC San Diego 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Iksuda Therapeutics at World ADC San Diego 2026
Oct 12–15, 2026 San Diego, CA ~1.3k attendees Website
Iksuda Therapeutics takes part in 10 sessions at World ADC San Diego 2026 in San Diego. It opens the plenary on validating new ADC mechanisms and designs, and its sessions centre on standing out in crowded clinical indications and linking ADC design to clinical results. It presents IKS073, an ADC whose first-in-class payload alkylates proteins instead of hitting topoisomerase I or tubulin, and the clinical profile of IKS014.
| Organization | World ADC San Diego 2026 Attendance |
|---|---|
Iksuda Therapeutics Newcastle upon Tyne, UK | |
UK ADC developer with clinical programs and new payload classes, including a protein-alkylating payload. | Chair Tue Oct 13 7:55am Chair’s Opening Remarks ADC discovery chemistryADC discovery biology Panel Tue Oct 13 8:00am Contextualizing the Current Status of Novel ADC Design & Development to Ensure Future ADC Success & Differentiated Patient Impact ADC discovery chemistryADC discovery biology Talk Tue Oct 13 2:00pm Talk Tue Oct 13 3:00pm Panel Tue Oct 13 3:30pm Panel Wed Oct 14 12:30pm Panel Wed Oct 14 3:00pm Chair Wed Oct 14 5:30pm Chair’s Closing Remarks Clinical development |
Instantly find 20 buyers from Iksuda Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World ADC or its organizers. Submit a correction